11
Sep
Roslin Innovation Centre

The new custom-built centre based at the University of Edinburgh’s allows us to meet increasing global demand for its cutting-edge gene control technology.

19
Apr

Synpromics, the leading synthetic promoter and gene control company, is pleased to announce that it has completed a financing round of £5.2M.

16
Mar

Edinburgh, UK, 16th March 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce it has been granted a key patent (EP2668277B1) by the European Patent Office, protecting PromPT™ - its proprietary synthetic promoter development platform.

04
Jan

Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform.

07
Dec

Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to expand the research collaboration with Adverum Biotechnologies that began in December 2015.

Pages